+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896654
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Eluting Balloon Market size was estimated at USD 965.84 million in 2023 and expected to reachUSD 1.09 billion in 2024, and is expected to grow at a CAGR of 15.51% to reachUSD 2.65 billion by 2030.

This catheter-based technology incorporates a balloon at its tip, which is coated with an anti-proliferative medication. When the balloon is inflated within the affected artery, it mechanically dilates the vessel to restore blood flow and also delivers the therapeutic agent directly to the arterial walls. This local drug delivery helps prevent restenosis, the re-narrowing of the artery, by inhibiting the growth of neointimal hyperplasia, a common cause of vessel re-occlusion. DEBs provide a targeted pharmacological approach that complements the mechanical intervention, offering an alternative to traditional therapies such as bare-metal or drug-eluting stents. The growth of the drug eluting balloon market is primarily driven by the rising prevalence of cardiovascular diseases globally and the subsequent increase in demand for minimally invasive surgical procedures. However, the stringent regulatory approval processes can impede the market's progression. Additionally, high costs associated with DEB treatments may deter potential markets in developing countries. Despite challenges, technological advancements improving the efficacy and safety of DEBs, along with enhanced patient recovery times, present future market opportunities. Rising reimbursement policies favoring DEB procedures in developing nations create new avenues for market expansion.

Regional Insights

In the Americas, the market for drug-eluting balloons (DEBs) has been experiencing robust growth driven by several factors, including the rising prevalence of peripheral and coronary artery diseases and increased awareness of the benefits of DEBs over traditional therapies. The United States is a major contributor in this region owing to its advanced healthcare infrastructure, favorable reimbursement policies, and presence of significant market players. The region's growth is further supported by numerous clinical trials and research studies validating the efficacy and safety of DEB therapy. The EMEA region presents a diverse market landscape for DEBs. In Europe, the adoption of DEBs is gaining momentum, especially in Western European countries, with higher accessibility to new medical devices and a strong presence of established companies. The Middle East and Africa present untapped opportunities with gradual growth, propelled by improving healthcare infrastructure and increasing investment in the healthcare sector. The Asia-Pacific market for DEBs is showing significant growth potential, with the burgeoning population, the increasing incidence of diabetes-induced vascular diseases, and escalating healthcare expenditures. Moreover, APAC's market is being stimulated by the rising number of local manufacturers and favorable government initiatives to enhance healthcare infrastructure.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Drug Eluting Balloon Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing Geriatric Population Leading to Cardiovascular Diseases
  • Rising Prevalence of Peripheral and Coronary Artery Diseases
  • Favorable Approvals to Support the Growth of DEBs

Market Restraints

  • Issues Associated to Product Recalls of Drug-Eluting Balloons

Market Opportunities

  • New Developments in the Clinical Use of Drug-Coated Balloon Catheters
  • Advancement, Innovation, and Research in Drug-Coated Balloons

Market Challenges

  • Lack of Availability for Skilled and Trained Professionals

Market Segmentation Analysis

  • Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
  • Coating Technology: Growing preferences for enduraCoat with better local drug release profile
  • End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug Eluting Balloon Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug Eluting Balloon Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)

Advanced NanoTherapies Inc., an innovator in nanotechnology for vascular disease treatment, announced the successful completion of a USD 4 Million Series A funding extension from a reputable yet undisclosed strategic medical device company. This injection of funds is expected to fortify ANT's clinical development activities and expedite its trajectory toward securing U.S. IDE approval for its SirPlux Duo Drug-Coated Balloon (DCB).

Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands

Translumina recently announced the strategic acquisition of Blue Medical Devices, a pioneer in producing state-of-the-art balloon catheters, including Drug Coated Balloons (DCB), situated in Helmond, Netherlands. With this purchase, Translumina expands its European footprint but also enhances its portfolio of coronary intervention solutions by incorporating Blue Medical's advanced DCB technologies.

Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

Surmodics, Inc. announced a significant advance with the FDA's approval of its state-of-the-art SurVeil drug-coated balloon (DCB). Specifically designed for treating peripheral artery disease, the SurVeil DCB can now be distributed in the United States for percutaneous transluminal angioplasty procedures on femoral and popliteal arteries.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug Eluting Balloon Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Balton Sp. z o. o., Bayer AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cardionovum GmbH, Concept Medical, Cook Medical, Inc., Eurocor Tech GmbH, Invamed, iVascular S.L.U., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Laborie Medical Technologies, Inc., Lepu Medical Technology, M.A. Med Alliance SA by Cordis Corporation, Medtronic PLC, SurModics, Inc., Terumo Corporation, Wellinq, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon

Coating Technology

  • EnduraCoat
  • FreePac
  • Paccocath
  • TransPax

End User

  • Ambulatory Surgery Centers
  • Cath Labs
  • Hospitals

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
5.1.1.3. Favorable Approvals to Support the Growth of DEBs
5.1.2. Restraints
5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
5.1.3. Opportunities
5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
5.1.4. Challenges
5.1.4.1. Lack of Availability for Skilled and Trained Professionals
5.2. Market Segmentation Analysis
5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Drug Eluting Balloon Market, by Type
6.1. Introduction
6.2. Coronary Drug Eluting Balloon
6.3. Peripheral Drug Eluting Balloon
7. Drug Eluting Balloon Market, by Coating Technology
7.1. Introduction
7.2. EnduraCoat
7.3. FreePac
7.4. Paccocath
7.5. TransPax
8. Drug Eluting Balloon Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Cath Labs
8.4. Hospitals
9. Americas Drug Eluting Balloon Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Drug Eluting Balloon Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Drug Eluting Balloon Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. DRUG ELUTING BALLOON MARKET RESEARCH PROCESS
FIGURE 2. DRUG ELUTING BALLOON MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG ELUTING BALLOON MARKET DYNAMICS
FIGURE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG ELUTING BALLOON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CORONARY DRUG ELUTING BALLOON, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PERIPHERAL DRUG ELUTING BALLOON, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY ENDURACOAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY FREEPAC, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY PACCOCATH, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY TRANSPAX, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY CATH LABS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DRUG ELUTING BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 51. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 54. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 55. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. CANADA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 60. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 61. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. MEXICO DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES DRUG ELUTING BALLOON MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 85. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 88. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 89. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 90. CHINA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 91. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 94. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 95. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 96. INDIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 103. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. JAPAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 142. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 143. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 144. THAILAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 160. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 161. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. DENMARK DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 168. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 169. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. EGYPT DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. FINLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. FRANCE DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 188. GERMANY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 200. ITALY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 216. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 217. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 218. NORWAY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 219. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. POLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 230. QATAR DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 252. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 253. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. SPAIN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 267. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. TURKEY DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY COATING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM DRUG ELUTING BALLOON MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. DRUG ELUTING BALLOON MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. DRUG ELUTING BALLOON MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Balton Sp. z o. o.
  • Bayer AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical
  • Cook Medical, Inc.
  • Eurocor Tech GmbH
  • Invamed
  • iVascular S.L.U.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Laborie Medical Technologies, Inc.
  • Lepu Medical Technology
  • M.A. Med Alliance SA by Cordis Corporation
  • Medtronic PLC
  • SurModics, Inc.
  • Terumo Corporation
  • Wellinq
  • Zylox-Tonbridge Medical Technology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.65 Billion
Compound Annual Growth Rate15.5%
Regions CoveredGlobal

Related Topics

Related Reports

Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Peripheral Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Peripheral Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 273 Pages
  • Global
From
Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 - Product Image

Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031

  • Report
  • 218 Pages
  • Global
Drug Eluting Balloons Catheters Global Market Report 2024 - Product Image

Drug Eluting Balloons Catheters Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Drug Eluting Balloons (DEBs) - Global Strategic Business Report - Product Image

Drug Eluting Balloons (DEBs) - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.